Obesity-drug developer BioAge Labs Inc. gained about 20% after its initial public offering on Thursday, while natural-gas ...

BKV Corporation plans to raise $300 million in a U.S. IPO. Read more on whether investors should consider this energy player.

Texas-based Barnett Shale driller prices below the estimated range, while obesity-drug developer BioAge prices midrange ahead ...

BKV Corp. priced its common shares at $18 each after and will begin trading on Sept. 26, about two years after the Denver ...

(Reuters) -Shares of BKV rose 3.1% in their debut on the New York Stock Exchange on Thursday, giving the U.S. natural gas ...

Natural gas producer BKV Corp said on Wednesday it had raised $270 million in its U.S. initial public offering.

BKV Corporation BKV IPO will take place September, 26 on the NYSE exchange under the ticker BKV. The company is offering shares at an expected price between $19.00 and $21.00 per share with an insider ...

The U.S. IPO market has bounced back strongly in 2024 after a nearly two-year dry spell, driven by receding recession fears ...

BioAge Labs (BIOA), which is developing a drug to augment popular weight-loss medications such as Wegovy and Zepbound, has upsized its proposed IPO. Read more here.

The Dallas-based company focuses on so-called outparcels, properties that point directly onto high-traffic roads that are visible to consumers, and Illinois is its largest market.

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.